TABLE 6.

Fatty acid compositions of the phospholipids in plasma from the healthy subjects and COVID-19 patients.

Fatty Acid (%)	Healthy subjects	COVID-19 patients	p
C16:0	26.34 ± 0.62	33.47 ± 0.71	0.001
C16:1	3.20 ± 0.31	2.78 ± 0.26	NS
C18:0	5.57 ± 0.21	9.77 ± 0.32	0.001
C18:1n-9	26.81 ± 0.84	24.18 ± 0.57	0.01
C18:2n-6	33.18 ± 0.89	23.96 ± 0.62	0.001
γ-C18:3n-6	0.31 ± 0.04	0.21 ± 0.03	0.001
α-C18:3n-6	0.48 ± 0.03	0.52 ± 0.07	NS
C20:3n-6	1.40 ± 0.16	2.61 ± 0.17	0.001
C20:4n-6	2.61 ± 0.19	2.35 ± 0.13	NS
C20:5n-3	0.03 ± 0.01	0.06 ± 0.02	NS
C22:6n-3	0.01 ± 0.009	0.04 ± 0.01	NS

Data represent the weights of each individual FA/weights of total FAs as percentages (mean ± SE) Fatty acid nomenclature: C16:0, palmitic acid; C16:1n-7, palmitoleic acid; C18:0, stearic acid; C18:1n-9, oleic acid; C18:2n-6, linoleic acid; γ-C18:3n-6, γ-linolenic acid; α-C18:3n-3, α-linolenic acid; C20:3n-6, dihomo-γ-linolenic acid; C20:4n-6, arachidonic acid; C20:5n-3 eicosapentaenoic acid; C22:6n-3, docosahexaenoic acid. The bold values indicate significant changes.